Macrophage autophagy and lipid metabolism pathways

Macrophage autophagy and lipid metabolism pathways represent a complex integrated system responsible for maintaining cellular lipid homeostasis and regulating inflammatory responses. In macrophages, autophagy facilitates a specialized process known as lipophagy, where lipid droplets are sequestered into autophagosomes and delivered to lysosomes for degradation by lysosomal acid lipase (LAL). This process is critical for converting stored cholesteryl esters into free cholesterol, which is subsequently exported from the cell via ATP-binding cassette transporters like ABCA1 and ABCG1 to prevent the formation of foam cells (PubMed: 20018865, NIH: PMC3127173). Dysregulation of these pathways is a primary driver of atherosclerosis and other metabolic diseases, as impaired autophagy leads to the accumulation of lipids and the activation of the NLRP3 inflammasome (PubMed: 24663462). Therapeutic strategies often focus on inducing autophagy through mTOR inhibition or AMPK activation, or by stimulating downstream lipid efflux through Liver X Receptor (LXR) agonists. However, targeting these pathways requires precision to avoid systemic metabolic side effects or interference with the macrophage's role in innate immunity (PubMed: 21606605).

Other names

Macrophage lipophagyMacrophage lipid handlingAutophagy-mediated lipid degradationMacrophage cholesterol trafficking

Modulation of autophagic flux to enhance the sequestration and lysosomal degradation of lipid droplets (lipophagy), thereby facilitating the mobilization of cholesterol for efflux via transporters such as ABCA1 and ABCG1.